Susquehanna International Group
FULC icon

Susquehanna International Group’s Fulcrum Therapeutics FULC Stock Holding History

Susquehanna International Group’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
150,000
+9,500
+7% +$88.1K ﹤0.01% 7517
2025
Q4 		$1.59M Buy
140,500
+74,000
+111% +$753K ﹤0.01% 6116
2025
Q3 		$612K Sell
66,500
-58,500
-47% -$423K ﹤0.01% 8502
2025
Q2 		$860K Buy
125,000
+91,200
+270% +$488K ﹤0.01% 7818
2025
Q1 		$97.3K Sell
33,800
-239,200
-88% -$879K ﹤0.01% 11557
2024
Q4 		$1.28M Sell
273,000
-283,900
-51% -$1.05M ﹤0.01% 6352
2024
Q3 		$1.99M Buy
556,900
+425,600
+324% +$3.16M ﹤0.01% 5277
2024
Q2 		$814K Sell
131,300
-174,200
-57% -$1.32M ﹤0.01% 7082
2024
Q1 		$2.88M Buy
305,500
+1,500
+0.5% +$13.4K ﹤0.01% 4599
2023
Q4 		$2.05M Sell
304,000
-400
-0.1% -$1.77K ﹤0.01% 5286
2023
Q3 		$1.35M Buy
304,400
+18,400
+6% +$80.4K ﹤0.01% 5952
2023
Q2 		$944K Sell
286,000
-12,000
-4% -$35.3K ﹤0.01% 6813
2023
Q1 		$849K Buy
298,000
+54,600
+22% +$489K ﹤0.01% 7246
2022
Q4 		$1.77M Sell
243,400
-33,700
-12% -$220K ﹤0.01% 4941
2022
Q3 		$2.24M Buy
277,100
+71,200
+35% +$510K ﹤0.01% 4682
2022
Q2 		$1.01M Buy
205,900
+116,200
+130% +$1.14M ﹤0.01% 6518
2022
Q1 		$2.12M Buy
89,700
+43,400
+94% +$614K ﹤0.01% 5350
2021
Q4 		$819K Sell
46,300
-9,400
-17% -$186K ﹤0.01% 7822
2021
Q3 		$1.57M Buy
+55,700
New +$1.06M ﹤0.01% 6362

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Susquehanna International Group's FULC Position: Q1 2026 in Review

Susquehanna International Group increased its Fulcrum Therapeutics (FULC) stake by 15% in Q1 2026, buying an estimated $124K and bringing the position to 101,336 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #8543.

Susquehanna International Group first reported a position in FULC in Q3 2019 and has held it in 17 quarters since. The position peaked at $5.3M in Q1 2024. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Susquehanna International Group held 101,336 shares of Fulcrum Therapeutics worth $777K as of Q1 2026.
  • Susquehanna International Group bought 13,406 Fulcrum Therapeutics shares in Q1 2026, an estimated $124K.
  • Fulcrum Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8543 holding.
  • Susquehanna International Group first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • Susquehanna International Group's Fulcrum Therapeutics position peaked at $5.3M in Q1 2024.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.